✦ LIBER ✦

Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus

✍ Scribed by Joris W.F. Uges; Marc D. Van Huizen; Jeroen Engelsman; Erik B. Wilms; Daniel J. Touw; Els Peeters; Charles J. Vecht

Book ID: 109111041
Publisher: Wiley (Blackwell Publishing)
Year: 2009
Tongue: English
Weight: 148 KB
Volume: 50
Category: Article
ISSN: 0013-9580
DOI: 10.1111/j.1528-1167.2008.01889.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous Levetiracetam as first-line

Intravenous Levetiracetam as first-line treatment of status epilepticus in the elderly

✍ J. Fattouch; C. Di Bonaventura; S. Casciato; F. Bonini; S. Petrucci; L. Lapenta; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Pharmacodynamic and pharmacokinetic char

Pharmacodynamic and pharmacokinetic characteristics of intravenous drugs in status epilepticus

✍ Meir Bialer 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 71 KB

Efficacy and safety of intravenous lacos

Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus

✍ M. Z. Koubeissi; C. L. Mayor; B. Estephan; S. Rashid; N. J. Azar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 638 KB

Pharmacokinetics and pharmacodynamic eff

Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusion

✍ Jean L. Grem; Mary Quinn; Abdel Ismail; Chris H. Takimoto; Richard Lush; David J 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 243 KB

Effects of intravenous infusion of lidoc

Effects of intravenous infusion of lidocaine on its pharmacokinetics in conscious instrumented dogs

✍ Leock Y. Ngo; Yun K. Tam; Soheir Tawfik; Ronald T. Coutts; Murray R. Gray 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB

Pharmacokinetics of amphotericin B in ra

Pharmacokinetics of amphotericin B in rats as a function of dose following constant-rate intravenous infusion

✍ Hsiao-Hui Chow; Yuhong Wu; Michael Mayersohn 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 759 KB

## Abstract Amphotericin B (AmB) is widely used for the treatment of systemic mycoses. The current therapeutic regimens for this drug are complex and somewhat empirical, in part because of very limited information about the disposition kinetics of this agent. In this study, we examined the disposit